Internal Medicine, Rheumatology · Tupelo, MS
NPI
1538137989
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
845 S Madison St
Tupelo, MS, 38801
Phone (662) 377-5930
Groups this clinician bills Medicare through
Medicare paid, 2024
$320K
6,608 services
Medicare patients, 2024
1,894
Average age 73
Drug cost, 2024
$18.2M
12,489 prescriptions
Company payments, 2025
$248
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles King was code 99214 (office e&m - established), 3,745 times for 1,500 patients. In total Charles King billed 6,608 services in 20 codes, and Medicare paid $320K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-09-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 3,745 | 1,500 | $66.12 | $248K |
| 99213 Office E&M - Established | Facility | 670 | 505 | $45.46 | $30K |
| 20610 Joint Injection | Facility | 443 | 260 | $37.98 | $17K |
| 73130 X-ray - Upper Extremity | Facility | 413 | 206 | $5.91 | $2,442 |
| 77085 Standard X-ray | Facility | 379 | 379 | $14.09 | $5,341 |
| 73630 X-ray - Lower Extremity | Facility | 355 | 178 | $5.86 | $2,080 |
| 73560 X-ray - Lower Extremity | Facility | 230 | 118 | $5.58 | $1,284 |
| 20600 Joint Injection | Facility | 148 | 110 | $27.23 | $4,031 |
| 20605 Joint Injection | Facility | 138 | 108 | $28.50 | $3,933 |
| 99204 Office E&M - New | Facility | 47 | 47 | $94.27 | $4,431 |
| 99212 Office E&M - Established | Facility | 20 | 19 | $25.39 | $508 |
By year: 2022 $352K for 7,585 services; 2023 $337K for 7,438 services; 2024 $320K for 6,608 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles King prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,950 prescriptions and refills. In total Charles King wrote 12,489 Medicare prescriptions that cost $18.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,950 | 4,196 | 591 | $46K |
| Prednisone Generic | 1,864 | 4,414 | 652 | $10K |
| Hydroxychloroquine Sulfate Generic | 1,498 | 3,787 | 496 | $57K |
| Allopurinol Generic | 788 | 1,928 | 219 | $5,661 |
| Humira Pen Adalimumab | 744 | 751 | 110 | $5.1M |
| Leflunomide Generic | 658 | 1,627 | 232 | $40K |
| Alendronate Sodium Generic | 604 | 1,384 | 220 | $3,778 |
| Meloxicam Generic | 582 | 1,452 | 229 | $2,935 |
| Humira(Cf) Pen Adalimumab | 311 | 323 | 52 | $2.3M |
| Diclofenac Sodium Generic | 304 | 575 | 126 | $7,971 |
| Enbrel Sureclick Etanercept | 275 | 284 | 50 | $2.1M |
| Humira Adalimumab | 213 | 213 | 28 | $1.4M |
| Rinvoq Upadacitinib | 176 | 178 | 35 | $1.1M |
| Forteo Teriparatide | 172 | 172 | 33 | $667K |
| Celecoxib Generic | 169 | 418 | 63 | $6,088 |
Brand drugs: 3,180 claims; generic drugs: 9,293 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles King $248 ($248 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $85.97.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.